You just read:

Nektar Therapeutics Presents Data from First-in-Human Phase 1a Study on Novel T Regulatory Cell Stimulator, NKTR-358 at 2019 Annual Meeting of the American College of Rheumatology

News provided by

Nektar Therapeutics

Nov 10, 2019, 11:00 ET